Public health & disease

From disease eradication efforts to advances in vaccination and maternal health, this archive tracks real progress in public health. Stories here focus on what’s working — policies, interventions, and research that are improving and extending lives around the world.

X-ray image of the intestine, for article on dostarlimab bowel cancer trial

New bowel cancer drug is found to be 100% effective

By / / Good News For Humankind

Immunotherapy just delivered something almost unheard of in cancer research: every single one of 42 patients in a rectal cancer trial showed no detectable tumour after treatment with the drug dostarlimab. Even more encouraging, the first 24 patients have now been tracked for an average of 26 months, and their cancers haven’t come back. For people with this specific subtype, it could mean skipping the chemotherapy, radiation, and surgery that often leave lasting damage. Larger studies are now underway to confirm the findings, but the signal is remarkable. It’s a glimpse of where cancer care may be heading worldwide — treatments that work with the body’s own immune system, and let patients keep their lives intact.

Contraceptives, for article on free contraception program

Free contraception initiative helps Finland reduce teenage abortions by 66%

By / / Good News For Humankind

Free contraception cut Finland’s teen abortion rate by 66% over roughly two decades, one of the steepest drops ever recorded in a high-income country. The shift came when municipalities began quietly weaving no-cost birth control into the same youth clinics where teenagers already get vaccines and check-ups, no awkward conversations or out-of-pocket costs required. Researchers say the lesson is refreshingly simple: young people aren’t avoiding contraception because they don’t understand it, but because of cost, stigma, or logistics — and Finland removed all three. As governments worldwide search for ways to support young people’s health and futures, this offers a quietly powerful blueprint: trust teenagers, meet them where they are, and the rest tends to follow.

Holding breast cancer ribbon, for article on breast cancer recurrence blood test

New blood test can predict breast cancer return

By / / Good News For Humankind

A new blood test for breast cancer recurrence spotted returning disease an average of 15 months before symptoms or scans — and in one case, a full 41 months ahead of diagnosis. In a UK trial of 78 patients, the test correctly flagged every woman who later relapsed, scanning for 1,800 cancer-related mutations in tiny fragments of tumour DNA left circulating after treatment. Lead researcher Dr. Isaac Garcia-Murillas explained that dormant cells too few to show up on scans can trigger relapse years later — exactly the blind spot this test targets. If larger studies confirm the results, a simple blood draw could give oncologists precious extra time to act, reshaping how recurrence is caught worldwide.

A researcher handling a vaccine vial in a clinical lab for an article about cancer vaccine trials, for article on cancer chemotherapy, for article on personalized cancer vaccine

NHS launches world-first cancer vaccine matchmaking program in England

By / / Good News For Humankind

Cancer vaccine trials are now being fast-tracked through a landmark NHS program in England that matches patients with personalized mRNA vaccines built around their individual tumors. The Cancer Vaccine Launch Pad, operating across 30 hospitals, uses the same mRNA technology behind COVID-19 vaccines to design custom treatments targeting each patient’s unique cancer mutations. The program aims to eliminate remaining cancer cells after surgery before they can return. Early immune response data is encouraging, and a 2024 trial showed a 44% reduction in melanoma recurrence when similar vaccines were combined with immunotherapy.

Aral Sea time lapse 1989 2014, for article on Aral Sea afforestation

Uzbekistan plants millions of acres of forest where the Aral Sea once lay

By / / Good News For Humankind

Aral Sea afforestation has covered 1.7 million hectares of dried lakebed with saxaul trees and other desert-tolerant plants over the past five years, transforming what was once the world’s fourth-largest lake into a slowly recovering landscape. The work is led on the ground by Karakalpak communities, where women gather seeds each autumn and men join planting crews through the winter. A single mature saxaul shrub can hold back several tons of moving sand, shielding nearby towns from the toxic dust storms that have driven respiratory illness for decades. It’s an imperfect, weather-dependent effort — but a hopeful model for how nature-based restoration can heal landscapes that seemed beyond saving.

A neuron or nerve cell is an electrically excitable cell, for article on ALS synapse-regenerating pill

Breakthrough synapse-regenerating ALS pill moves to phase 2 human trials

By / / Good News For Humankind

A once-daily ALS pill designed to rebuild neural connections — not just slow their loss — has cleared FDA approval to begin Phase 2 trials, with patients across the U.S. starting doses in April 2024. SPG302 works on synapses, the tiny junctions where neurons talk to each other, which start vanishing before motor neurons themselves die. Every ALS drug currently on the market aims to slow decline; this one is being tested for whether it can actually help recover lost function. For the roughly 30,000 Americans living with ALS, that’s a genuinely different question to be asking. If it works, it could reshape how researchers approach neurodegenerative disease far beyond ALS.

Good news for public health, for article on CAB-LA HIV prevention, for article on lenacapavir HIV prevention, for article on HIV infections in young men

HIV transmissions in the U.S. dropped 12% between 2018 and 2002

By / / Good News For Humankind

HIV infections among young men in the U.S. dropped 30% between 2018 and 2022, the steepest decline of any age group in the latest CDC surveillance data. Researchers credit expanded testing, faster connection to treatment, and the growing reach of PrEP — a daily pill that cuts transmission risk by up to 99% when taken consistently. The South, long carrying the heaviest HIV burden in the country, saw the largest regional drop, and Black men experienced an 18% decline. Gaps remain, especially for transgender women and Latino gay men, but the news from this generation is genuinely hopeful: when prevention tools reach people early, they work. It’s a glimpse of what ending the epidemic could actually look like.

Packages of diapers, for article on Medicaid diaper coverage

Tennessee to become the first U.S. state to provide some children’s diapers

By / / Good News For Humankind

Free diapers through Medicaid are coming to Tennessee this August, with families receiving 100 a month for every child under two. It’s the first program of its kind in the country, and advocates expect it to deliver close to 100 million diapers a year to families who need them. The need is real: the National Diaper Bank Network found that 92% of Tennessee families receiving diaper assistance are working parents who still can’t afford enough. Local diaper banks helped lay the groundwork, and they’ll keep serving families the program doesn’t reach. Tennessee’s approach offers a tested path other states can follow, turning a quiet daily struggle into something a community can actually solve together.

Person touching pregnant belly with hands forming a heart, for article on LGBTQ+ fertility coverage

Aetna agrees to provide equal fertility coverage for LGBTQ+ people in the U.S. in landmark settlement

By / / Good News For Humankind

LGBTQ+ couples who were charged a “queer tax” of up to $100,000 for fertility treatment just won a major shift at Aetna, including a $2 million fund to reimburse families who paid out of pocket. The settlement ends a policy that required same-sex couples to fund a year of treatments themselves before coverage kicked in, while heterosexual couples qualified after a simple conversation. It started with Emma Goidel and Ilana Caplan, who drained their savings through multiple rounds of IUI and IVF before suing under the Affordable Care Act’s ban on sex discrimination in health care. Their win creates a template other insurers can follow, and a legal path other families can walk, toward fertility care that treats every family as worth building.

A rainforest river winding through dense green jungle in Suriname for an article about Suriname malaria-free certification, for article on dual-insecticide bed nets

New types of mosquito bed nets could cut malaria risk by up to half, trial finds

By / / Good News For Humankind

New mosquito bed nets cut malaria transmission by 20 to 50 percent in a major trial across 17 African countries, offering a real answer to the growing problem of insecticide resistance. The nets pair the standard pyrethroid coating with a second insecticide that hits mosquitoes through a different biological pathway, so the ones that used to shrug off treated nets no longer can. At under three dollars each, they cost about the same as the older versions they’re replacing. Paired with the malaria vaccine now rolling out across Africa, these nets are part of a layered defense that could meaningfully shift the trajectory of a disease that still kills hundreds of thousands of people every year.